BRCA Gene Mutations Explained
October 24, 2019
Pictured: NYITCOM student researcher Emily Seltzer and faculty researcher Dong Zhang, Ph.D., explore targeted breast cancer therapies.
Each October, Breast Cancer Awareness Month reminds us that one in eight women will be diagnosed with breast cancer in her lifetime.
For those with BRCA1 and BRCA2 gene mutations, the chances are even higher. The National Breast Cancer Foundation estimates that 55 to 65 percent of women with the BRCA1 mutation, and 45 percent of women with the BRCA2 mutation, will develop breast cancer before age 70.
Cancer researcher and BRCA gene expert, Dong Zhang, Ph.D., associate professor of biomedical sciences at NYIT College of Osteopathic Medicine, is investigating targeted therapies for a more effective and less toxic treatment for cancer.
Watch the video below to learn more about BRCA gene mutations and why there is hope.
Learn more about Zhang’s research.
More Features
An Alumnus’ Commitment to the Environment
As an energy management graduate from New York Tech’s Vancouver campus, Jasdeep Gulati (M.S. ’22) is highly invested in educating people about environmental and climate sustainability.
Vancouver Faculty Win University-Sponsored Research Awards in New Program
The new Global Impact Research Grant (GIRG) program has been developed to keep Vancouver-based faculty connected to faculty and research projects being conducted on the university’s New York campuses.
Studying Climate Change One Degree at a Time
Junhua Qu (M.S. ’24) began her collegiate journey in Beijing. But, her interest in climate change took her to New York Tech’s Vancouver campus to study energy management.